NewYorkTimes

Therapists are cautious about sharing personal information. When they fall ill or die unexpectedly, the shock can be shattering. View original article Contributor: Ellen Barry

PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times. View original article Contributor: Stephanie Nolen

Some women’s symptoms improved quickly after taking the pill, but depression persisted in others. Doctors are trying to learn which patients benefit, and why some don’t. View original article Contributor: Pam Belluck

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary. View original article Contributor: Ellen Barry

Researchers hope that a better understanding of which genes contribute to excess weight could help with prevention starting in childhood. View original article Contributor: Gina Kolata

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday. View original article Contributor: Benjamin Mueller and Christina Jewett

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major private insurers. View original article Contributor: Sarah Kliff

The start-up, called Truemed, helps people buy meat and mattresses with money that isn’t subject to federal income tax. But does the tax break apply? View original article Contributor: Ron Lieber and Benjamin Mueller

The company was accused of marketing its products to teenagers, causing a surge in use. View original article Contributor: Christina Jewett

Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been overstated. View original article Contributor: Roni Caryn Rabin